tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MGNX Stock Latest News

MacroGenics Advances in Cancer Treatment with MGC028 Clinical Trial
Company AnnouncementsMacroGenics Advances in Cancer Treatment with MGC028 Clinical Trial
8h ago
MGNX
MacroGenics’ Lorigerlimab Study: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
MacroGenics’ Lorigerlimab Study: A Potential Game-Changer in Cancer Treatment?
8h ago
MGNX
MacroGenics’ MGC026 Study: A New Hope for Advanced Cancer Treatment
PremiumCompany Announcements
MacroGenics’ MGC026 Study: A New Hope for Advanced Cancer Treatment
10h ago
MGNX
MacroGenics’ MGD024 Study: A New Hope for Blood Cancer Treatment?
PremiumCompany Announcements
MacroGenics’ MGD024 Study: A New Hope for Blood Cancer Treatment?
11h ago
MGNX
MacroGenics assumed with an Overweight at Barclays
PremiumThe Fly
MacroGenics assumed with an Overweight at Barclays
1M ago
MGNX
MacroGenics initiated with an Overweight at Barclays
PremiumThe FlyMacroGenics initiated with an Overweight at Barclays
1M ago
MGNX
MacroGenics’ Strategic Shift and Lorigerlimab’s Trial Impact: A Hold Rating Amid CEO Transition and Drug Development Uncertainty
Premium
Ratings
MacroGenics’ Strategic Shift and Lorigerlimab’s Trial Impact: A Hold Rating Amid CEO Transition and Drug Development Uncertainty
2M ago
MGNX
MacroGenics price target lowered to $5 from $8 at Leerink
Premium
The Fly
MacroGenics price target lowered to $5 from $8 at Leerink
2M ago
MGNX
MacroGenics Inc. Reports Q2 2025 Financial Results
PremiumCompany Announcements
MacroGenics Inc. Reports Q2 2025 Financial Results
2M ago
MGNX
Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
PremiumThe Fly
Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
2M ago
NUE
UNH
MacroGenics reports Q2 EPS (57c), consensus (38c)
PremiumThe Fly
MacroGenics reports Q2 EPS (57c), consensus (38c)
2M ago
MGNX
MacroGenics’ MGC026 Study: A New Hope for Advanced Solid Tumors?
PremiumCompany Announcements
MacroGenics’ MGC026 Study: A New Hope for Advanced Solid Tumors?
2M ago
MGNX
MacroGenics Appoints Eric Risser as New CEO
PremiumCompany AnnouncementsMacroGenics Appoints Eric Risser as New CEO
3M ago
8K
MGNX
MacroGenics CEO Scott Koenig steps down, Eric Risser succeeds
Premium
The Fly
MacroGenics CEO Scott Koenig steps down, Eric Risser succeeds
3M ago
MGNX
MGNX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
MGNX Earnings this Week: How Will it Perform?
3M ago
MGNX
MacroGenics’ Prostate Cancer Study: A Potential Game-Changer?
PremiumCompany Announcements
MacroGenics’ Prostate Cancer Study: A Potential Game-Changer?
3M ago
MGNX
MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment?
PremiumCompany Announcements
MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment?
3M ago
MGNX
MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors
PremiumCompany Announcements
MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors
3M ago
MGNX
MacroGenics Advances Cancer Treatment with MGC026 Study Update
PremiumCompany Announcements
MacroGenics Advances Cancer Treatment with MGC026 Study Update
4M ago
MGNX
MacroGenics Enters Royalty Purchase Agreement with Sagard
PremiumCompany AnnouncementsMacroGenics Enters Royalty Purchase Agreement with Sagard
5M ago
8K
MGNX
MacroGenics, Sagard Healthcare enter into ZYNYZ royalty purchase
Premium
The Fly
MacroGenics, Sagard Healthcare enter into ZYNYZ royalty purchase
5M ago
MGNX
MacroGenics Holds Annual Stockholders Meeting on May 21
Premium
Company Announcements
MacroGenics Holds Annual Stockholders Meeting on May 21
5M ago
8K
MGNX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >